Bristol HIV Price Cut Includes Pledge Not To Enforce Patent Rights In Africa

Bristol-Myers Squibb's HIV drug price cut for sub-Saharan African countries includes a pledge not to enforce patent rights for Videx (didanosine) and Zerit (stavudine).

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet